| Literature DB >> 25689281 |
Marc S Tibber1, Elaine J Anderson2, Tracy Bobin3, Patricia Carlin4, Sukhwinder S Shergill3, Steven C Dakin5.
Abstract
Schizophrenia has been linked to impaired performance on a range of visual processing tasks (e.g. detection of coherent motion and contour detection). It has been proposed that this is due to a general inability to integrate visual information at a global level. To test this theory, we assessed the performance of people with schizophrenia on a battery of tasks designed to probe voluntary averaging in different visual domains. Twenty-three outpatients with schizophrenia (mean age: 40±8 years; 3 female) and 20 age-matched control participants (mean age 39±9 years; 3 female) performed a motion coherence task and three equivalent noise (averaging) tasks, the latter allowing independent quantification of local and global limits on visual processing of motion, orientation and size. All performance measures were indistinguishable between the two groups (ps>0.05, one-way ANCOVAs), with one exception: participants with schizophrenia pooled fewer estimates of local orientation than controls when estimating average orientation (p = 0.01, one-way ANCOVA). These data do not support the notion of a generalised visual integration deficit in schizophrenia. Instead, they suggest that distinct visual dimensions are differentially affected in schizophrenia, with a specific impairment in the integration of visual orientation information.Entities:
Mesh:
Year: 2015 PMID: 25689281 PMCID: PMC4331538 DOI: 10.1371/journal.pone.0117951
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical data for the participants with schizophrenia.
| Diag | Sex | Age | Med | Type | Dose | IQ | tPANSS | tPSS | tNSS | tGSS | tDIS | DIS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SZ | M | 39 | Aripiprazole | 2nd | 133 | 95 | 44 | 9 | 12 | 23 | 9 | 1 |
| PS | M | 30 | Clozapine | 2nd | 1000 | 106 | 58 | 12 | 20 | 26 | 9 | 1 |
| PS | M | 30 | Olanzapine | 2nd | 400 | 102 | 47 | 7 | 17 | 23 | 10 | 1 |
| SZ | F | 38 | Clozapine | 2nd | 800 | 100 | 100 | 20 | 28 | 52 | 15 | 4 |
| SZ | M | 40 | Risperidone | 2nd | 100 | 106 | 76 | 14 | 30 | 32 | 14 | 3 |
| PS | M | 49 | Haloperidol | 1st | 200 | 98 | 48 | 13 | 11 | 24 | 9 | 2 |
| SZ | M | 33 | Olanzapine | 2nd | 400 | 105 | 69 | 14 | 20 | 35 | 9 | 3 |
| PS | M | 48 | Olanzapine | 2nd | 400 | 100 | 67 | 18 | 21 | 28 | 10 | 1 |
| PS | M | 42 | Clozapine | 2nd | 750 | 101 | 59 | 13 | 14 | 32 | 9 | 1 |
| SZ | M | 31 | Quetiapine | 2nd | 1066 | 112 | 61 | 15 | 16 | 30 | 11 | 2 |
| SZ | F | 50 | Pipotiazine | 1st | 150 | 112 | 61 | 21 | 11 | 29 | 12 | 3 |
| PS | M | 53 | Clozapine | 2nd | 1000 | 89 | 40 | 12 | 9 | 19 | 8 | 2 |
| SZ | M | 36 | Olanzapine | 2nd | 200 | 111 | 42 | 7 | 14 | 21 | 8 | 1 |
| PS | M | 43 | Clozapine | 2nd | 1200 | 86 | 63 | 15 | 16 | 32 | 9 | 3 |
| PS | M | 28 | Pipotiazine | 1st | 200 | 101 | 64 | 11 | 23 | 30 | 14 | 3 |
| PS | M | 46 | Clozapine | 2nd | 600 | 117 | 47 | 8 | 12 | 27 | 8 | 1 |
| SZ | M | 53 | - | - | 150 | 95 | 73 | 16 | 25 | 32 | 11 | 1 |
| PS | M | 28 | Clozapine | 2nd | 500 | 84 | 53 | 9 | 20 | 24 | 14 | 3 |
| SZ | M | 31 | Clozapine | 2nd | 800 | 100 | 63 | 13 | 18 | 32 | 10 | 1 |
| PS | M | 45 | Olanzapine | 2nd | 400 | 105 | 65 | 17 | 19 | 29 | 12 | 3 |
| PS | F | 43 | Quetiapine | 2nd | 1400 | 117 | 55 | 12 | 17 | 26 | 11 | 2 |
| PS | M | 40 | Clozapine | 2nd | 300 | 113 | 34 | 7 | 11 | 16 | 5 | 1 |
| SZ | M | 45 | Olanzapine | 2nd | 200 | 94 | 47 | 12 | 12 | 23 | 8 | 1 |
| Mean | - | 40 | - | - | 537 | 102 | 58 | 13 | 17 | 28 | 10 | 2 |
| Stdev | - | 8 | - | - | 389 | 9 | 14 | 4 | 6 | 7 | 2 | 1 |
The following information is provided: diagnosis (Diag; SZ = schizophrenia; PS = Paranoid schizophrenia), medication (Med), medication type (Type: 1st = first generation antipsychotic; 2nd = second generation antispsychotic), medication dose (Dose: chlorpromazine equivalent in mg/day), intelligence quotient (IQ / NART score), total scores for the entire PANSS test (tPANSS), total scores for the positive symptoms of the PANSS test (tPSS), total scores for the negative symptoms of the PANSS test (tNSS), total scores for the general symptoms of the PANSS test (tGSS), scores on a cognitive factor which overlaps heavily with the concept of disorganization syndrome (tDIS) and scores for item P2 on the PANSS test, “conceptual disorganization” (DIS).
Fig 1Psychophysical procedures.
(A) Example high (100%) and low (20%) coherence motion stimuli. Signal dots are shown in white and noise dots in black. Directions of motion are indicated by the orientation of the arrow-heads. (Note: in the actual experiment all dots were white). Below each example stimulus is shown the corresponding idealised distribution of signal values (solid black line) and noise values (dark grey shaded region). In the coherence task, noise was increased by changing the proportion of signal to noise dots. (B) Zero and high noise motion stimuli, with corresponding distributions of motion directions presented below. (C) The equivalent noise fit (solid black line) is constrained by two data-points: the ‘zero noise’ threshold, which represents the minimum directional offset that can be reliably discriminated, and the ‘high noise’ threshold, which represents the maximum level of noise that can be tolerated while discriminating between large directional offsets (±45°). The fitting-function (inset in C) has two parameters: internal noise and global sampling. (D) and (E) show zero and high noise orientation and size stimuli, for orientation and size judgements, respectively. The schematics below show corresponding distributions of orientations / sizes. In (A, B, D & E), the reference direction / orientation / size is denoted by a vertical black dotted line; the average signal direction / orientation / size is circled.
Fig 2Coherence and equivalent noise plots.
Group mean (A) coherence thresholds, (B) levels of internal noise and (C) sampling are shown for control participants and participants with schizophrenia. Error bars denote the standard error of the mean. Deg. = degrees. ** p = 0.01.
Comparing group performance on motion coherence and equivalent noise tasks.
| F | d.f. |
| Partial-η2 | ||
|---|---|---|---|---|---|
|
| Th | 0.25 | 1,35 | 0.62 | 0.01 |
|
| σint | 3.62 | 1,33 | 0.07 | 0.1 |
|
| 0.22 | 1,31 | 0.64 | 0.01 | |
|
| σint | 0.20 | 1,33 | 0.70 | 0.01 |
|
| 7.14 | 1,31 | **0.01 | 0.19 | |
|
| σint | 2.00 | 1,33 | 0.17 | 0.06 |
|
| 2.46 | 1,31 | 0.13 | 0.07 |
Schizophrenia and control group performances were compared using a series of one-way analyses of covariance with IQ scores included as a covariate. These analyses were undertaken on filtered data. See text however for details of analyses undertaken on non-filtered (raw) data with and without IQ included as a covariate. F = F-statistic; d.f. = degrees of freedom; p = significance level; Partial-η2 = effect size; Th = motion coherence threshold; σint = internal noise; n samp = sampling.
Partial and standard bivariate correlations between psychophysical performance and clinical measures / IQ.
| Motion | Orientation | Size | ||||||
|---|---|---|---|---|---|---|---|---|
| Th | σint |
| σint |
| σint |
| ||
|
|
| 0.07 | -0.20 | -0.26 | 0.06 | 0.08 | -0.17 | -0.03 |
|
| 0.78 | 0.43 | 0.32 | 0.83 | 0.75 | 0.50 | 0.90 | |
|
|
| -0.32 | -0.28 | -0.02 | -0.01 | 0.03 | 0.18 | 0.13 |
|
| 0.21 | 0.28 | 0.95 | 0.96 | 0.92 | 0.48 | 0.62 | |
|
|
| 0.23 | -0.03 | -0.39 | 0.15 | -0.09 | -0.43 | -0.18 |
|
| 0.37 | 0.90 | 0.13 | 0.56 | 0.73 | 0.09 | 0.50 | |
|
|
| 0.15 | -0.22 | -0.21 | 0.01 | 0.22 | -0.13 | -0.01 |
|
| 0.57 | 0.40 | 0.42 | 0.98 | 0.41 | 0.62 | 0.97 | |
|
|
| 0.13 | -0.05 | -0.25 | 0.21 | -0.16 | -0.27 | -0.26 |
|
| 0.61 | 0.85 | 0.33 | 0.42 | 0.53 | 0.30 | 0.32 | |
|
|
| 0.07 | 0.10 | -0.13 | 0.05 | -0.08 | -0.10 | -0.07 |
|
| 0.79 | 0.71 | 0.63 | 0.84 | 0.76 | 0.70 | 0.79 | |
|
|
| -0.32 | -0.27 | 0.04 | 0.04 | 0.40 | -0.04 | 0.26 |
|
| 0.21 | 0.30 | 0.89 | 0.89 | 0.12 | 0.88 | 0.32 | |
|
|
| -0.48 | -0.25 | 0.19 | -0.07 | -0.18 | 0.18 | 0.36 |
|
| 0.02 | 0.27 | 0.41 | 0.77 | 0.42 | 0.40 | 0.09 | |
Partial correlations are shown for psychophysical and clinical variables for participants with schizophrenia whilst controlling for the effects of IQ scores (all rows except bottom two). Standard bivariate correlations are also shown for psychophysical measures and IQ scores (bottom two rows). R = Pearson’s correlation coefficient; p = significance level; Th = motion coherence threshold; σint = internal noise; n samp = sampling. See legend to Table 1 for further details of abbreviations used for clinical measures.